Nanovis Spine received 510(k) clearance from the U.S. Food and Drug Administration for its FortiCore interbody fusion devices.
The FortiCore implants include highly porous titanium scaffold engineered for strong, durable integration with a PEEK core. The implants are the first of three technology platforms that Nanovis plans to bring to the spine and orthopedic markets.
"Nanovis' mission is to lead our chosen markets with science-enhanced implants that improve lives. Based on our exiting preclinical data, the FortiCore interbody platform certainly promises to fulfill that mission," said Matt Hedrick, Nanovis' CEO.
More articles on devices:
FDA clears Life Spine's expandable lateral interbody system
SpineGuard revenue drops 6% in 2014 so far: 10 key concepts
SI-BONE receives 13th patent